Novel coronavirus pandemic: A clinical overview

Area of Science:

• Public Health
• Infectious Diseases
• Epidemiology

Background:

• The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019, rapidly escalating into a global health crisis.
• The ongoing pandemic has resulted in millions of reported cases and hundreds of thousands of deaths worldwide within six months.
• Transmission occurs primarily through inhalation of or contact with infected respiratory droplets.

Purpose of the Study:

• To provide an overview of the SARS-CoV-2 outbreak, including its origin, transmission, clinical presentation, and epidemiological impact.
• To compare the case fatality rate of SARS-CoV-2 with previous coronavirus outbreaks.
• To highlight the current management strategies and the uncertainties surrounding the long-term consequences of the pandemic.

Main Methods:

• This study is a review of existing data and literature on the SARS-CoV-2 outbreak.
• Epidemiological data on cases and deaths were compiled from global reports.
• Clinical information on disease presentation and progression was synthesized from available medical literature.

Main Results:

• The majority of coronavirus disease 2019 (COVID-19) patients exhibit mild symptoms, but approximately 20% develop moderate-to-severe illness.
• A subset of severe cases (around 5%) may progress to critical conditions such as pneumonia, acute respiratory distress syndrome, and multi-organ dysfunction.
• The case fatality rate for SARS-CoV-2 appears lower compared to SARS-CoV and MERS-CoV.

Conclusions:

• Supportive care is currently the cornerstone of managing COVID-19 patients due to the absence of a specific medical treatment.
• The full extent of the pandemic's impact on global health, social structures, and economies remains to be determined.
• Continued global surveillance and research are essential for understanding and mitigating the long-term effects of SARS-CoV-2.